|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1992-4-2
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The mechanism by which cAMP-dependent protein kinase-catalyzed phosphorylation modulates the activities of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase was examined after site-specific mutation of the cAMP-dependent phosphorylation site (Ser32) to aspartic acid or alanine. The mutant and wild-type enzymes were overexpressed in Escherichia coli in a rich medium to levels as high as 30 mg/liter and were then purified to homogeneity. The kinetic properties of the Ser32-Ala mutant were identical with the dephosphorylated wild-type bifunctional enzyme. Mutation of Ser32 to aspartic acid mimicked several effects of cAMP-dependent phosphorylation: there was an increase in the Km for fructose 6-phosphate for 6-phosphofructo-2-kinase and an increase in the maximal velocity of fructose-2,6-bisphosphatase. Fructose-2,6-bisphosphatase activity of the Ser32-Asp mutant was 75% that of the phosphorylated wild-type enzyme, the mutant's kinase reaction had an identical dependence on fructose 6-phosphate, while its maximum velocity was only 60% that of the phosphorylated wild-type enzyme over a wide pH range. Furthermore, catalytic subunit-catalyzed in vitro phosphorylation of the Ser32-Ala mutant on Ser33 increased the Km for fructose 6-phosphate by 4-fold for the 6-phosphofructo-2-kinase. The results support the hypothesis that Ser32 is an important residue in the regulation of the activities of the bifunctional enzyme and that phosphorylation of Ser32 can be functionally substituted by aspartic acid. The results suggest a role for negative charge in the effect of phosphorylation.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0021-9258
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
5
|
|
pubmed:volume |
267
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4416-23
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:1339450-Animals,
pubmed-meshheading:1339450-Circular Dichroism,
pubmed-meshheading:1339450-Electrophoresis, Polyacrylamide Gel,
pubmed-meshheading:1339450-Kinetics,
pubmed-meshheading:1339450-Liver,
pubmed-meshheading:1339450-Molecular Sequence Data,
pubmed-meshheading:1339450-Mutagenesis, Site-Directed,
pubmed-meshheading:1339450-Mutation,
pubmed-meshheading:1339450-Peptide Mapping,
pubmed-meshheading:1339450-Phosphofructokinase-2,
pubmed-meshheading:1339450-Phosphoric Monoester Hydrolases,
pubmed-meshheading:1339450-Phosphorylation,
pubmed-meshheading:1339450-Phosphotransferases,
pubmed-meshheading:1339450-Protein Kinases,
pubmed-meshheading:1339450-Rats,
pubmed-meshheading:1339450-Recombinant Proteins,
pubmed-meshheading:1339450-Serine,
pubmed-meshheading:1339450-Substrate Specificity,
pubmed-meshheading:1339450-Trypsin
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Properties of phospho- and dephospho- forms and of two mutants in which Ser32 has been changed by site-directed mutagenesis.
|
|
pubmed:affiliation |
Department of Physiology and Biophysics, State University of New York, Stony Brook 11794-8661.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, Non-U.S. Gov't
|
